Katy Anne Trampel

6PUBLICATIONS
14CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Coding, information theory and compressionExercise physiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 24, 2026
RNAi-mediated p38δ silencing mitigates anthracycline cardiotoxicity in female mice.

Katy A Trampel, Katherine Y Gross, Daniel O'Reilly

|Jul 24, 2025
Coordinated Tbx3/Tbx5 transcriptional control of the adult ventricular conduction system.

Ozanna Burnicka-Turek, Katy A Trampel, Brigitte Laforest

|Apr 30, 2024
Moderate Endurance Exercise Increases Arrhythmia Susceptibility and Modulates Cardiac Structure and Function in a Sexually Dimorphic Manner.

Sharon A George, Katy Anne Trampel, Kelsey Brunner

|Aug 25, 2023
Anthracycline cardiotoxicity is exacerbated by global p38β genetic ablation in a sexually dimorphic manner but unaltered by cardiomyocyte-specific p38α loss.

Sharon A George, Alexi Kiss, Katy Anne Trampel

|Aug 11, 2023
Ryanodine receptor inhibition with acute dantrolene treatment reduces arrhythmia susceptibility in human hearts.

Sharon A George, Jaclyn A Brennan-McLean, Katy A Trampel

Pageof 1